According to the expression of ER, PR, HER2 and Ki67, all breast cancer patients were classified into molecular classification (Table 3), among which 12 cases of Luminal B(HER2-) became Basal type, accounting for the highest proportion. This evidence concerns the gene MKI67 and breast carcinoma.